Flash FinanceUS
Market closed S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · Pediatrix Medical (MD)

Pediatrix Medical Group shareholders approve 8 million share increase to incentive plan

Neutral Impact 2 of 5 shareholder Written later

At its May 7, 2026 annual meeting, Pediatrix Medical Group's shareholders approved the Second Amended and Restated 2008 Incentive Compensation Plan, which adds 8,000,000 shares for issuance under the plan. All nine director nominees were elected, and shareholders ratified PricewaterhouseCoopers LLP as auditor and approved executive pay on an advisory basis. John M. Starcher, Jr. received notably more votes against than for, which shareholders may wish to note.

Key points

  • Plan approved with 65,912,243 votes for and 6,303,675 against; the plan adds 8,000,000 shares
  • John M. Starcher, Jr. received 46,296,745 votes for and 25,909,618 against in his director election
  • PricewaterhouseCoopers LLP ratified as 2026 independent auditor with 75,519,473 votes for

The filing

CompanyPediatrix Medical (MD)
Form8-K, current report
Filed with the SECMay 7, 2026, 4:30 PM ET
Accession number0001193125-26-212117

Items reported: 5.02 Director / Officer Change5.07 Shareholder Vote Results

Read the filing on SEC.gov ↗

Written by AI on Nov 8, 2026, 6:56 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on May 07, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.